Nuo Therapeutics, Inc. Cash And Cash Equivalents At Carrying Value

• Nuo Therapeutics, Inc. showed an increase of +93.5% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
• This data is from Nuo Therapeutics, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
• XBRL data for this metric is available from 2013 to 2025 (20 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 20 years of available data (2013 to 2025), Nuo Therapeutics, Inc.'s Cash And Cash Equivalents At Carrying Value has declined by 83.3%.
• Historical annual values: Fiscal year 2025: $548.9 thousand | Fiscal year 2024: $283.7 thousand | Fiscal year 2023: $928.7 thousand | Fiscal year 2022: $2.05 million | Fiscal year 2021: $1.41 million | Fiscal year 2021: $148.4 thousand | Fiscal year 2021: $151.6 thousand | Fiscal year 2021: $157.3 thousand | Fiscal year 2020: $161.4 thousand | Fiscal year 2020: $0.00 | Fiscal year 2020: $13.00 | Fiscal year 2020: $11.2 thousand | Fiscal year 2019: $20.3 thousand | Fiscal year 2018: $636.9 thousand | Fiscal year 2017: $693.5 thousand | Fiscal year 2016: $2.62 million | Fiscal year 2016: $10.36 million | Fiscal year 2015: $922.3 thousand | Fiscal year 2014: $15.95 million | Fiscal year 2013: $3.29 million.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026